SPECT/CT融合显像骨转移癌诊断价值分析  

Diagnostic Value of SPECT/CT Fusion Imaging in Bone Metastatic Carcinoma

作　　者：何涛[1] 李玉峰[2] 

机构地区：[1]四川省攀枝花市中心医院核医学科,攀枝花617067 [2]四川省攀枝花市中心医院超声科,攀枝花617067

出　　处：《中国医药导刊》2017年第1期57-58,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:对SPECT/CT融合显像骨转移癌诊断价值的分析与探讨。方法:随机选取在笔者所在医院接受诊断的恶性肿瘤患者,采用不同方法进行治疗,对治疗结果进行对比分析。结果:SPECT/CT组的检查灵敏度指标、特异度指标等指标都优于骨显像组,组间差异具有统计学意义(P<0.05)。结论:对疑似骨转移癌患者,优先采用SPECT/CT诊断法,能够显著提高诊断效率。Objective：To evaluate the value of SPECT / CT fusion imaging in the diagnosis of bone metastases.Methods：Malignant tumor patients were randomly selected and treated with different methods.The results of treatment were compared and analyzed.Results：The diagnostic sensitivity index and specificity index of SPECT/CT group were better than those of bone imaging group,the difference was significant statistically（P〈0.05）.Conclusion：In patients with suspected bone metastases,SPECT/CT diagnosis is preferred,and the diagnostic efficiency can be improved significantly.

关 键 词：SPECT/CT诊断 全身骨显像诊断 骨转移癌 诊断价值分析 

分 类 号：R738.1[医药卫生—肿瘤] R730.44[医药卫生—临床医学]